Fast-Acting Migraine Treatment

Tags:
Migraine, Treatments, Sumavel, DosePro, Fast-acting, Needle-free, Subcutaneous, Zogenix, Healthcare

Add video views to your Facebook Timeline:

Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.

To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/

  1. By: MultiVu
  2. Categories News & Events
  3. Views 14
  4. Added :06-Jun-11
Comments on Fast-Acting Migraine Treatment
Other comments on this video 0 Comments